On the other hand, the actual GLP-1 microneedle patches with GLP-1 analogues like semaglutide are said to show results like reduced appetite and cravings, feelings of fullness and delayed gastric emptying 4
Based on early human studies and animal research, GLP-1 agonists may affect: Reward-related eating behaviours by potentially modulating dopamine signalling in brain reward circuits Food cravings and hedonic eating (eating for pleasure rather than hunger) Impulsivity around food , possibly reducing the compulsive aspects of eating Satiety signalling , enhancing the feeling of fullness after meals Some patients using GLP-1 medications for diabetes or weight management report not just reduced appetite but also diminished preoccupation with food, fewer intrusive thoughts about eating, and reduced cravings for specific foods, particularly those high in fat and sugar
If youre experiencing moderate to severe gastrointestinal side effects from your GLP-1, maintaining hydration is important for oral health and replacing fluid lost through vomiting or diarrhea
Following this, Banting signed a contract with Connaught Laboratories of the University of Toronto for the large-scale production of their insulin extract which they used to successfully treat a further six patients